nav-left cat-right
cat-right

Good vibrations: Using light-heated water to deliv...

Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body. This discovery represents a major innovation, said Adah Almutairi, PhD, associate professor...

GlaxoSmithKline joins a $115M antibiotics developm...

Resistance to antibacterials is fast becoming one of the most urgent public health problems, especially since the pipeline for new antibiotics largely has dried up after Big Pharma’s retreat from the field in recent years. To help combat growing antimicrobial resistance, more than 30 European universities, research institutions and drug companies are joining together to launch a 6-year, €85 million ($115.5 million)...

11th Anti-infectives Partnering and Deal-Making Co...

GTC’s 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a...

Big Pharma superteam joins NIH to share data

The National Institutes of Health has persuaded 10 rival drugmakers to briefly set aside their competitive spirits and collaborate on drug discovery projects in four major diseases, pooling their data and expertise to kick-start early-stage efforts. Under the 5-year plan, the drugmakers will contribute some of their brightest minds in Alzheimer’s, Type 2 diabetes, rheumatoid arthritis and lupus, working with NIH in a...

Sony teams with Illumina working on Japanese genom...

Sony has struggled financially in recent years, with its shrinking share of the TV market and a sector-wide slump in PC sales dragging the company down. With the electronics business floundering, management is looking to other sectors to prop up the business and thinks it has found the next growth engine–genomics. The Japanese business ($SNE) is entering the sector by setting up a company called P5. It’s...

Biogen Idec, Proteostasis forge neurodegenerative ...

CAMBRIDGE, Mass.—Alzheimer’s disease, and some of its neurodegenerative cousins, came under fire from a new direction as Proteostasis Therapeutics Inc. this month brought in the R&D and clinical firepower of fellow Cambridge-based company Biogen Idec. in a worldwide collaboration agreement. The deal combines Proteostasis Therapeutics’ proprietary scientific platform and preclinical work on protein degradation with...
Page 3 of 3112345...102030...Last »